Silence Therapeutics Announces Preliminary Single Dose Results From SLN124 Phase 1 Study In Patients With Benzinga
Source link
Silence Therapeutics Announces Preliminary Single Dose Results From SLN124 Phase 1 Study In Patients With Benzinga
Source link